Astellas Pharma Inc. (ALPMF) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Drug Manufacturers - General उद्योग. कंपनी का मुख्यालय है Tokyo, Japan. वर्तमान CEO हैं Naoki Okamura.
ALPMF के पास है IPO तिथि 2010-04-26, 14,754 पूर्णकालिक कर्मचारी, पर सूचीबद्ध Other OTC, बाजार पूंजीकरण $29.61B.
Astellas Pharma Inc. is a Japan-based pharmaceutical company founded in 1923 that manufactures, markets, and distributes medicines globally across oncology, urology, immunology, and infectious disease. The company's key products include XTANDI for prostate cancer, XOSPATA for acute myeloid leukemia, PADCEV for urothelial cancer, Myrbetriq for overactive bladder, Evrenzo for anemia in chronic kidney disease, and Prograf for transplant immunosuppression. Astellas maintains an extensive pipeline and strategic partnerships with leading institutions including Merck, Harvard University, and CytomX Therapeutics, as well as collaborations in emerging areas such as targeted radiotherapy, cell therapy, and epigenetic research. The company is headquartered in Tokyo and operates a diversified portfolio of prescription and specialty pharmaceutical products serving major markets worldwide.
